Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Chien

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|June 4, 2011
Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcriptionChristopher D Chien, Alexander Kirilyuk, Jordan V Li, et al.
Science Translational Medicine|November 24, 2017
TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearanceYinmeng Yang, M Eric Kohler, Christopher D Chien, et al.
Molecular and Cellular Biology|September 4, 2008
Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cellsAnnabell S Oh, John T Lahusen, Christopher D Chien, et al.
Blood|August 1, 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDChristian M Capitini, Nicole M Nasholm, Christopher D Chien, et al.
The Prostate|January 21, 2006
In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer modelsStanley T Fricke, Olga Rodriguez, John Vanmeter, et al.
Haematologica|August 11, 2022
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaLisa M Niswander, Zachary T Graff, Christopher D Chien, et al.
Journal for Immunotherapy of Cancer|September 17, 2021
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct designHaiying Qin, Lila Yang, John A Chukinas, et al.
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
The Journal of Clinical Investigation|September 14, 2020
Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patientsKazusa Ishii, Marie Pouzolles, Christopher D Chien, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|June 4, 2011
Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcriptionChristopher D Chien, Alexander Kirilyuk, Jordan V Li, et al.
Science Translational Medicine|November 24, 2017
TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearanceYinmeng Yang, M Eric Kohler, Christopher D Chien, et al.
Molecular and Cellular Biology|September 4, 2008
Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cellsAnnabell S Oh, John T Lahusen, Christopher D Chien, et al.
Blood|August 1, 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDChristian M Capitini, Nicole M Nasholm, Christopher D Chien, et al.
The Prostate|January 21, 2006
In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer modelsStanley T Fricke, Olga Rodriguez, John Vanmeter, et al.
Haematologica|August 11, 2022
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaLisa M Niswander, Zachary T Graff, Christopher D Chien, et al.
Journal for Immunotherapy of Cancer|September 17, 2021
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct designHaiying Qin, Lila Yang, John A Chukinas, et al.
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
The Journal of Clinical Investigation|September 14, 2020
Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patientsKazusa Ishii, Marie Pouzolles, Christopher D Chien, et al.
Pageof 3